Insiders / Bienaime Jean Jacques / Activity
Activity — Bienaime Jean Jacques
25 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| May 26, 2026 | Other | INCY Incyte Corp Common Stock | $1.27M | -13K -36.44% | 22,782 0.01% of shares | low |
| May 26, 2026 | Exercise | INCY Incyte Corp Common Stock | $1.27M | +15K +71.97% | 35,841 0.02% of shares | low |
| Jun 5, 2026 | Sell | IMNM Immunome Inc. Common Stock | $194.1K | -10K -23.30% | 32,915 0.03% of shares | medium |
| Jun 5, 2026 | Buy | IMNM Immunome Inc. Common Stock | $116.9K | +6K +18.23% | 38,915 0.03% of shares | medium |
| May 15, 2026 | Buy | IMNM Immunome Inc. Common Stock | $103.5K | +5K +13.02% | 43,415 0.04% of shares | medium |
| Jun 5, 2026 | Buy | IMNM Immunome Inc. Common Stock | $68.1K | +4K +8.99% | 42,415 0.04% of shares | medium |
| May 26, 2026 | Buy | ASND Ascendis Pharma A/S Ordinary Shares | $47.9K | +200 +100.00% | 400 <0.01% of shares | low |
| May 26, 2026 | Buy | ASND Ascendis Pharma A/S Ordinary Shares | $47.2K | +200 | 200 <0.01% of shares | low |
| May 29, 2026 | Buy | ASND Ascendis Pharma A/S Ordinary Shares | $44.8K | +200 +50.00% | 600 <0.01% of shares | low |
| May 29, 2026 | Buy | ASND Ascendis Pharma A/S Ordinary Shares | $44.5K | +200 +33.33% | 800 <0.01% of shares | low |
| Mar 9, 2026 | Buy | KROS Keros Therapeutics, Inc. Common Stock | $22.4K | +2K +36.70% | 7,450 0.04% of shares | low |
| May 29, 2026 | Buy | ASND Ascendis Pharma A/S Ordinary Shares | $22.4K | +100 +12.50% | 900 <0.01% of shares | low |
| Mar 10, 2026 | Buy | IMNM Immunome Inc. Common Stock | $22.1K | +1K +2.75% | 37,415 0.03% of shares | low |
| Mar 11, 2026 | Buy | IMNM Immunome Inc. Common Stock | $21.6K | +1K +2.67% | 38,415 0.03% of shares | low |
| Jun 5, 2026 | Buy | IMNM Immunome Inc. Common Stock | $19.3K | +1K +2.36% | 43,415 0.04% of shares | low |
| Apr 15, 2026 | Buy | KROS Keros Therapeutics, Inc. Common Stock | $11.7K | +1K +13.42% | 8,450 0.04% of shares | low |
| May 15, 2026 | Buy | KROS Keros Therapeutics, Inc. Common Stock | $10.6K | +1K +11.83% | 9,450 0.05% of shares | low |
| Jun 15, 2026 | Buy | KROS Keros Therapeutics, Inc. Common Stock | $10.2K | +1K +6.03% | 17,592 0.09% of shares | low |
| Jun 5, 2026 | Sell | IMNM Immunome Inc. Common Stock | $9.7K | -500 -1.15% | 42,915 0.04% of shares | low |
| Jun 8, 2026 | Grant | INCY Incyte Corp Common Stock | $0 | +2K +7.21% | 24,424 0.01% of shares | low |
| Jun 3, 2026 | Grant | KROS Keros Therapeutics, Inc. Common Stock | $0 | +7K +75.58% | 16,592 0.08% of shares | low |
| Jun 10, 2026 | Grant | IMNM Immunome Inc. Director Stock Option (right to buy) | — | +10K | 9,897 <0.01% of shares | low |
| Jun 8, 2026 | Grant | INCY Incyte Corp Non Qualfied Stock Option (right to buy) | — | +6K | 6,111 <0.01% of shares | low |
| Jun 3, 2026 | Grant | KROS Keros Therapeutics, Inc. Stock Option (right to buy) | — | +7K | 7,433 0.04% of shares | low |
| May 26, 2026 | Exercise | INCY Incyte Corp Non-Qualified Stock Option (right to buy) | — | -15K -100.00% | 0 0.00% of shares | low |